Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy

Cited by (377)

Items 201–300 of 377

1. Protective effects of bendazac lysine on early experimental diabetic nephropathy in rats
   Xiaoxing Yin, Yindi Zhang, Jianping Shen, Haiwei Wu, Xiang Zhu, Limin Li, Jun Qiu, Shaojun Jiang, Xiaogang Zheng · 2005 · Acta Pharmacologica Sinica
2. GLP-1 agonists in the treatment of chronic kidney disease in type 2 diabetes and obesity
   Cooper, Mark E., van Raalte, Daniël H. · 2025 · Journal of Clinical Investigation
3. Repurposing drugs for highly prevalent diseases: pentoxifylline, an old drug and a new opportunity for diabetic kidney disease
   Javier Donate‐Correa, María Dolores Sánchez-Niño, Ainhoa González-Luis, Carla María Ferri, Alberto Martín-Olivera, Ernesto Martín‐Núñez, Beatriz Fernández‐Fernández, Víctor G. Tagua, Carmen Mora Fernández, Alberto Ortíz et al. · 2022 · Clinical Kidney Journal
4. Induction of experimental diabetes and diabetic nephropathy using anomer-equilibrated streptozotocin in male C57Bl/6J mice
   Sarah Kamli-Salino, Paul A. Brown, Timo N. Haschler, Lihuan Liang, Denis Féliers, Heather M. Wilson, Mirela Delibegović · 2023 · Biochemical and Biophysical Research Communications
5. Plasma endothelin-1 level, measured glomerular filtration rate and effective renal plasma flow in diabetic nephropathy
   Radmila Žeravica, Velibor Čabarkapa, Branislava Ilinčić, Vladimir Sakač, Romana Mijović, Stanislava Nikolić, Z Stosić · 2015 · Renal Failure
6. Disruption of Aldehyde Reductase Increases Group Size in Dictyostelium
   Karen Ehrenman, Yang Gong, Wan-Pyo Hong, Tong Gao, Wonhee Jang, Debra A. Brock, R. Diane Hatton, James D. Shoemaker, Richard H. Gomer · 2004 · Journal of Biological Chemistry
7. Agents in development for the treatment of diabetic nephropathy
   Kei Fukami, Mark Emmanuel Cooper, Josephine Maree Forbes · 2005 · Expert Opinion on Investigational Drugs
8. Endothelial nitric oxide synthase gene (T786C and G894T) polymorphisms in Egyptian patients with type 2 diabetes
   Omneya Moguib, Hala M. Raslan, Inas Abdel Rasheed, Laila K. Effat, Nadia Mohamed, Safaa Elserougy, Ghada Hussein, Salwa Tawfeek, Amany H. Abdelrahman, Khalda Omar · 2017 · Journal of Genetic Engineering and Biotechnology
9. Circadian Clock Genes in Diabetic Kidney Disease (DKD)
   Olanrewaju A. Olaoye, Sarah Masten, Rajesh Mohandas, Michelle L. Gumz · 2019 · Current Diabetes Reports
10. Increased levels of YKL-40 in patients with diabetes mellitus: a systematic review and meta-analysis
    Wanwan Luo, Lingmin Zhang, Lingling Sheng, Zhencheng Zhang, Zaixing Yang · 2021 · Diabetology & Metabolic Syndrome
11. Urocortin 1 improves renal function in rats with streptozotocin‐induced diabetes by inhibiting overproduction of TGF‐β1 and VEGF
    Xuan Li, Jue Hu, Qichun Zhang, Xiaoyu Sun, Shengnan Li · 2009 · British Journal of Pharmacology
12. Les récepteurs de la bradykinine : de nouveaux rôles physiopathologiques
    Jean‐Loup Bascands, Joost Peter Schanstra, Réjean Couture, Jean‐Pierre Girolami · 2003 · médecine/sciences
13. Development of diabetic nephropathy in the Milan normotensive strain, but not in the Milan hypertensive strain: Possible permissive role of hemodynamics
    Giuseppe Pugliese, Flavia Pricci, Paola Barsotti, Carla Iacobini, Carlo Ricci, Giovanna Oddi, Giulio R. Romeo, Gaetano Leto, Giuseppe Marano, Mariella Sorcini et al. · 2005 · Kidney International
14. Targeting the epidermal growth factor receptor (EGFR/ErbB) for the potential treatment of renal pathologies
    Mohamed Mahmoud Tawengi, Yazan Al-Dali, Abdelaziz M. Tawengi, Ibrahim F. Benter, Saghir Akhtar · 2024 · Frontiers in Pharmacology
15. Integrated multiple-microarray analysis and mendelian randomization to identify novel targets involved in diabetic nephropathy
    Chenyu Fan, Yuye Gao, Ying Sun · 2023 · Frontiers in Endocrinology
16. Role of kidney ADP-ribosyl cyclase in diabetic nephropathy
    Seon-Young Kim, Kwang‐Hyun Park, Rukhsana Gul, Kyu Yun Jang, Uh‐Hyun Kim · 2008 · American Journal of Physiology-Renal Physiology
17. Protective Effects of Swertiamarin against Methylglyoxal-Induced Epithelial-Mesenchymal Transition by Improving Oxidative Stress in Rat Kidney Epithelial (NRK-52E) Cells
    Kirti Parwani, Farhin Patel, Dhara N. Patel, Palash Mandal · 2021 · Molecules
18. Therapeutic Interruption of Advanced Glycation in Diabetic Nephropathy
    Karly C. Sourris, Josephine Maree Forbes, Mark Emmanuel Cooper · 2008 · Annals of the New York Academy of Sciences
19. Advanced glycation end products and insulin resistance in diabetic nephropathy
    Kirti Parwani, Palash Mandal · 2024 · Vitamins and hormones
20. Transplantation of human fetal pancreatic progenitor cells ameliorates renal injury in streptozotocin-induced diabetic nephropathy
    Yong-Wei Jiang, Wen-Jian Zhang, Shi-Qing Xu, Hua Lin, Wei-Guo Sui, Honglin Liu, L. Peng, Qing Fang, Li Chen, J. Lou · 2017 · Journal of Translational Medicine
21. Correlation of Pentosidine with Kidney Diseases in Iraqi Patients with Diabetic Nephropathy
    Ghada Salam Hamid, Ali A. Allawi, Kadhim K. Ghudhaib · 2021 · Iraqi Journal of Science
22. An analysis of citations to retracted articles in the scientific literature
    Mary E. Gabehart · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
23. Effect of Angiotensin II on Glomerular Structure in Streptozotocin-Induced Diabetic Rats
    Susanne B. Nicholas, Michael S. Mauer, John M. Basgen, Elsa Aguiniga, Yun Chon · 2004 · American Journal of Nephrology
24. Effect of dopamine D3 receptor blockade on renal function and glomerular size in diabetic rats
    Gerd Luippold, Martina Beilharz, Manfred Wehrmann, Liliane Unger, Gerhard Groß, Bernd Mühlbauer · 2005 · Naunyn-Schmiedeberg s Archives of Pharmacology
25. Sphingosine Kinase-1/sphingosine 1-phosphate pathway in diabetic nephropathy
    Deng Yanhui, Tian Lan, Huang Juan, Huang Heqing · 2014 · Chinese Medical Journal
26. Complications of Diabetes Mellitus
    Michael Brownlee, Lloyd Paul Aiello, Mark Emmanuel Cooper, Aaron I. Vinik, Richard W. Nesto, Andrew J.M. Boulton · 2011 · Elsevier eBooks
27. Transforming Growth Factor-β1 Production Is Correlated With Genetically Determined ACE Expression in Congenic Rats
    María E. Pueyo, Mireille Challah, Dominique Gauguier, Liliane Louedec, M. Philippe, Roger Gaertner, Michel Marre, Jean‐Baptiste Michel, Marie‐Paule Jacob · 2004 · Diabetes
28. Determination of Ghrelin Immunoreactivity in Kidney Tissues of Diabetic Rats
    Tuncay Kuloğlu, Dürrin Özlem Dabak · 2009 · Renal Failure
29. Plant Compounds for the Treatment of Diabetes, a Metabolic Disorder: NF-κB as a Therapeutic Target
    Sahukari Ravi, Jyothi Punabaka, Bhasha Shanmugam, Venkata Subbaiah Ganjikunta, Kondeti Ramudu Shanmugam, Sathyavelu Reddy Kesireddy · 2020 · Current Pharmaceutical Design
30. Pathophysiology of Diabetic Nephropathy
    Charbel C. Khoury, Sheldon Chen, Fuad N. Ziyadeh · 2019 · Elsevier eBooks
31. 2-Dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione, isolated from the root of Averrhoa carambola L., protects against diabetic kidney disease by inhibiting TLR4/TGFβ signaling pathway
    Hongliang Zhang, Shunyu Lu, Lixiu Chen, Xiang Huang, Luhui Jiang, Yuchun Li, Peiyu Liao, Xingchun Wu, Xin Zhou, Luhui Qin et al. · 2020 · International Immunopharmacology
32. Non-Albumin Proteinuria (NAP) as a Complementary Marker for Diabetic Kidney Disease (DKD)
    Jaehyun Bae, Young Jun Won, Byung‐Wan Lee · 2021 · Life
33. MECHANISM OF DIABETIC NEPHROPATHY: ROLE OF PROTEIN KINASE-C ACTIVATION —
    Yuzuru Ohshiro, Yvonne Lee, George Liang King · 2005
34. Gene networks implicated in diabetic kidney disease.
    Weifeng Tang, Yue-Ming Gao, Yunfeng Li, Gengsheng Shi · 2012 · PubMed
35. Glomerular barrier dysfunction in glomerulosclerosis‐ resistant Milan rats with experimental diabetes: the role of renal haemodynamics
    Giuseppe Pugliese, Pier Carlo Ricci, Carla Iacobini, Stefano Menini, Paola Fioretto, Mara Ferrandi, LA Giardino, Silvia Armelloni, Deborah Mattinzoli, Mp Rastaldi et al. · 2007 · The Journal of Pathology
36. Diabetic patients and kidney protection: an attainable target
    David Barit, Mark Emmanuel Cooper · 2008 · Journal of Hypertension
37. Advancements, Challenges, and clinical implications of integration of metabolomics technologies in diabetic nephropathy
    Vijay Kumar Sharma, Manoj Khokhar, P. Panigrahi, A. Gadwal, P. Setia, P. Purohit · 2024 · Clinica Chimica Acta
38. Sitagliptin ameliorates high glucose-induced cell proliferation and expression of the extracellular matrix in glomerular mesangial cells
    Guan-Ying Zhang, Dongdong Wang, Zheng Cao, Tong Wei, Chen-Xu Liu, Qun-Li Wei · 2017 · Experimental and Therapeutic Medicine
39. Apelin: A potential novel serum biomarker for early detection of diabetic nephropathy in patients with type 2 diabetes
    Mustafa Demirpençe · 2018 · Northern Clinics of Istanbul
40. Changes in soluble tumor necrosis factor receptor type 1 levels and early renal function decline in patients with diabetes
    Richard J. MacIsaac, Matthew Farag, Varuni R. Obeyesekere, Michele V. Clarke, Ray Boston, Glenn M. Ward, George Jerums, Elif Ilhan Ekinci · 2019 · Journal of Diabetes Investigation
41. Hydration and Kidney Health
    Nadine Bouby, William F. Clark, Ronan Roussel, Christopher Taveau, Connie J. Wang · 2014 · Obesity Facts
42. Role of TGF-β/GLUT1 axis in susceptibility vs resistance to diabetic glomerulopathy in the Milan rat model
    Pier Carlo Ricci, Carla Iacobini, Giovanna Oddi, Lorena Amadio, Stefano Menini, Maria Pia Rastaldi, Aurora Frasheri, Flavia Pricci, Francesco Rocco Pugliese, Giuseppe Pugliese · 2006 · Nephrology Dialysis Transplantation
43. Hepato-renal protective effects of gallic acid and p-coumaric acid in nicotinamide/streptozotocin-induced diabetic rats
    Adel Abdel Moneim*, Sanaa Mahmoud Abd El-Twab, Mohamed Badr Ashour, Ahmed I. Yousef · 2016 · International Journal of Bioassays
44. Effect of short‐term hyperglycaemia on haemodynamics in type 1 diabetic patients
    Peter Karl Jacobsen, Kasper Rossing, Birgitte V. Hansen, Peter Bie, Allan Arthur Vaag, H.‐H. Parving · 2003 · Journal of Internal Medicine
45. KIOM-79 prevents S100b-induced TGF-β1 and fibronectin expression in mouse mesangial cells
    Dong Ho Jung, Young Sook Kim, Jin Sook Kim · 2009 · Journal of Ethnopharmacology
46. Expression of CD4+CD28nullT lymphocytes in children and adolescents with type 1 diabetes mellitus: Relation to microvascular complications, aortic elastic properties, and carotid intima media thickness
    Mona H. El-Samahy, Azza Abdel Gawad Tantawy, Amira A. M. Adly, Nevin Mohamed Mamdouh Habeeb, Eman Abdel Rahman Ismail, Gehan Mostafa Hamed, Rasha Eladawy · 2017 · Pediatric Diabetes
47. Deletion of MK2 signalling in vivo inhibits small Hsp phosphorylation but not diabetic nephropathy
    J.-K. Park, Natalia Ronkina, Andy Höft, C. Prohl, J. Menne, Matthias Gaestel, Hermann G. Haller, Matthias Meier · 2008 · Nephrology Dialysis Transplantation
48. The impact of the novel starch-lipid complexes on the glucolipids metabolism, inflammation, and gut dysbiosis of type 2 diabetes mellitus rats
    Yingshuang Lu, Renbing Qin, Jin Wang, Fengjuan Xiang, Yan Zhang, Bowei Zhang, Dancai Fan, Huan Lv, Xuemeng Ji, Shujun Wang et al. · 2024 · Food Science and Human Wellness
49. Circular RNAs and the regulation of gene expression in diabetic nephropathy (Review)
    Maximo Berto Benitez, Yussel Pérez‐Navarro, Elisa Irene Azuara-Liceaga, Angeles Cruz, Jesús Flores, Lilia López‐Cánovas · 2024 · International Journal of Molecular Medicine
50. Potential of Modulating Aldosterone Signaling and Mineralocorticoid Receptor with microRNAs to Attenuate Diabetic Kidney Disease
    Shinji Hagiwara, Tomohito Gohda, Phillip Kantharidis, Jun Okabe, Maki Murakoshi, Yusuke Suzuki · 2024 · International Journal of Molecular Sciences
51. What Are New Avenues for Renal Protection, in Addition to RAAS Inhibition?
    Shinji Hagiwara, Phillip Kantharidis, Mark Emmanuel Cooper · 2012 · Current Hypertension Reports
52. The association between monocyte HDL ratio and albuminuria in diabetic nephropathy
    Fatma Kaplan Efe · 2021 · Pakistan Journal of Medical Sciences
53. LncRNA NNT-AS1 regulates proliferation, ECM accumulation and inflammation of human mesangial cells induced by high glucose through miR-214-5p/smad4
    Zhuang Geng, Xiang Wang, Shiyuan Hao, Bingzi Dong, Yajing Huang, Yangang Wang, Lili Xu · 2021 · BMC Nephrology
54. Molecular mechanisms of proteinuria in diabetes
    Luigi Gnudi · 2008 · Biochemical Society Transactions
55. PATHOGENESIS OF DIABETIC NEPHROPATHY
    Atul Arya, Sahil Aggarwal, Harlokesh Naryan Yadav · 2010
56. Role of caveolae in high glucose and TGF-β₁ induced fibronectin production in rat mesangial cells.
    Yuantao Liu, Shengxia Lu, Yuchao Zhang, Xiangdong Wang, Feng Kong, Ye Liu, Peng Li, Yuqin Fu · 2014 · Europe PMC (PubMed Central)
57. The role of the TSC-22 (−396) A/G variant in the development of diabetic nephropathy
    Fumiaki Sugawara, Yuichiro Yamada, Rie Watanabe, Nobuhiro Ban, Kazumasa Miyawaki, Akira Kuroe, Akihiro Hamasaki, Hiroki Ikeda, Takeshi Kurose, Masaru Usami et al. · 2003 · Diabetes Research and Clinical Practice
58. Prevention of Diabetic Nephropathy by Modified Acidic Fibroblast Growth Factor
    Ana María Sánchez Peña, Shali Chen, Biao Feng, Lu Cai, Xiaokun Li, Guang Liang, Subrata Chakrabarti · 2017 · The Nephron journals/Nephron journals
59. Benazepril hydrochloride improves diabetic nephropathy and decreases proteinuria by decreasing ANGPTL-4 expression
    Lingyu Xue, Xiaoqing Feng, Chuanhai Wang, Xuebin Zhang, Wenqiang Sun, YU Ke-bo · 2017 · BMC Nephrology
60. Renal and cerebral RAS interaction contributes to diabetic kidney disease.
    Yufeng Liu, Lanying Li, Minzi Qiu, Lishan Tan, Mengbi Zhang, Jiawen Li, Hongguo Zhu, Shaoling Jiang, Xiaoyan Su, Aiqing Li · 2019 · PubMed Central
61. Design, synthesis, and biological evaluation of 1,2,4‐oxadiazole‐containing pyrazolo[3,4‐b]pyridinones as a new series of AMPKɑ1β1γ1 activators
    Zhihong Xiao, Yajun Peng, Bifeng Zheng, Qi Chang, Yating Guo, Zhuo Chen, Qianbin Li, Gaoyun Hu · 2021 · Archiv der Pharmazie
62. Pathophysiology and Pathogenesis of Diabetic Nephropathy
    Sheldon Chen, Charbel C. Khoury, Fuad N. Ziyadeh · 2012 · Elsevier eBooks
63. Review: Preventing End-Stage Renal Disease in Diabetic Patients — Dual Blockade of the Renin-Angiotensin System (Part II)
    Peter Karl Jacobsen · 2005 · Journal of the Renin-Angiotensin-Aldosterone System
64. Metabolic Memory in the Autonomic Neuropathy of Diabetes
    Nish Chaturvedi · 2009 · Circulation
65. Biomarkers and signaling pathways of diabetic nephropathy and peripheral neuropathy: possible therapeutic intervention of rutin and quercetin
    Tamsheel Fatima Roohi, Seema Mehdi, Sadaf Aarfi, Kamsagara Linganna Krishna, Suman Pathak, Seikh Mohammad Suhail, Syed Faizan · 2023 · Diabetology International
66. ASSESSMENT OF NEPHRIN AND PODOCIN LEVELS IN THE URINE OF PATIENTS WITH DIABETES MELLITUS
    Irina Nikolaevna Bobkova, А. А. Щукина, Marina Vladimirovna Shestakova · 2017 · Nephrology (Saint-Petersburg)
67. Matrix metalloproteinase-9 gene polymorphism (-1562 C/T) and its correlation with diabetic nephropathy
    Kholoud Shalaby, Rania Bahriz, Nancy Mahsoub, Mohammed M. El-Arman, Ghada El‐Said · 2021 · The Egyptian Journal of Internal Medicine
68. Expression of Angiopoetin-Like Protein-4 and Kidney Injury Molecule-1 as Preliminary Diagnostic Markers for Diabetes-Related Kidney Disease: A Single Center-Based Cross-Sectional Study
    Gulnaz Bano, Mohammad Tarique Imam, Ram Chandra Bajpai, Ghada M. Alem, Varun Kumar Kashyap, Anwar Habib, Abul Kalam Najmi · 2023 · Journal of Personalized Medicine
69. Renal effects of dual renin–angiotensin–aldosterone system blockade in patients with diabetic nephropathy
    Michele Dalla Vestra, Natalino Simioni, Alessandra Masiero · 2008 · International Urology and Nephrology
70. Pathophysiology of Diabetic Nephropathy
    Charbel C. Khoury, Sheldon Chen, Fuad N. Ziyadeh · 2014 · Elsevier eBooks
71. Role of upstream stimulatory factor 2 in diabetic nephropathy
    Shuxia Wang · 2015 · Frontiers in Biology
72. Urinary excretion of markers for podocyte injury in patients with diabetes mellitus
    А. А. Щукина, I N Bobkova, Marina Vladimirovna Shestakova, Ol'ga Konstantinovna Vikulova, З. Т. Зураева, Olga Mikhaleva · 2015 · Terapevticheskii arkhiv
73. The Ku protein family regulates hyperglycemia-induced vascular endothelial cell inflammation by modulating P300 levels
    Qinqin Cai, Qiao Ling Zhao, Qingxia Yang, Min Sheng Zhu, Fufen Meng, Jihong Jiang · 2024 · Experimental Cell Research
74. Brain signalling systems: A target for treating type I diabetes mellitus
    Ramugounder Ramakrishnan · 2019 · Brain Research Bulletin
75. Is diabetic nephropathy disappearing from clinical practice?
    Mark Emmanuel Cooper · 2006 · Pediatric Diabetes
76. Pyridoxamine ameliorates the effects of advanced glycation end products on subtotal nephrectomy induced chronic renal failure rats
    Yao Chen Chuang, Ming‐Shiou Wu, Tai-Hsien Wu, Yi-Kai Su, Yi-Min Lee · 2012 · Journal of Functional Foods
77. Renal functional changes in relation to hemodynamic parameters during exercise test in normoalbuminuric insulin‐dependent children
    Ann M. Raes, Dirk Matthys, Raymond A.M.G. Donckerwolcke, Margaretha Craen, Sara Van Aken, Johan Vande Walle · 2007 · Acta Paediatrica
78. Biochemical effects of irbesartan in experimental diabetic nephropathy
    Richa Vaishya, J Singh, Harbans Lal · 2009 · Indian Journal of Pharmacology
79. Endothelial Function and Dysfunction
    Coen D.A. Stehouwer, Casper G. Schalkwijk · 2003
80. Evidential support for garlic supplements against diabetic kidney disease: a preclinical meta-analysis and systematic review
    Yayi Jiang, Zihan Li, Rensong Yue, Guojie Liu, Maoyi Yang, Caiyi Long, Dawei Yan · 2023 · Food & Function
81. Histological analysis of five organs in streptozotocin-induced diabetic rats
    Tae Woo Oh, Seok Yong Kang, Yong-Ki Park · 2013 · The Korea Journal of Herbology
82. The pathogenesis of diabetic nephropathy
    Richard E. Gilbert, Mark Emmanuel Cooper · 2003 · CRC Press eBooks
83. Long-term administration of sopungsungi-won (SP) prevents diabetic nephropathy in zucker diabetic fatty rats
    Youn Young Kim, Kwi Man Kang, Sung Hyun Chung · 2002 · Archives of Pharmacal Research
84. Future Strategies to Prevent Renal Microvascular Disease Complications in Diabetes
    Janaka J. Karalliedde, Luigi Gnudi · 2007 · Future Cardiology
85. Influence of Acute High Glucose on Protein Abundance Changes in Murine Glomerular Mesangial Cells
    Michelle T. Barati, James C. Gould, Sarah A. Salyer, Susan M. Isaacs, Daniel Wade Wilkey, Michael L. Merchant · 2015 · Journal of Diabetes Research
86. The link between Glut-1 and hypertension in diabetic nephropathy
    Luigi Gnudi, Leopoldo R. Raij · 2006 · Current Hypertension Reports
87. Cost-Effectiveness Analysis of Renin-Angiotensin Aldosterone System Blockade in Progression of Chronic Kidney Disease
    Oraluck Pattanaprateep, Atiporn Ingsathit, Mark McEvoy, John Attia, Ammarin Thakkinstian · 2018 · Value in Health Regional Issues
88. Diabetische Nephropathie
    Jan Menne, Hermann G. Haller · 2011 · Der Internist
89. Role of Magnesium in Diabetic Nephropathy for Better Outcomes
    Mahesh Mamilla, Sai Goutham Reddy Yartha, Richa Tuli, Sunil Konipineni, Dharma Teja Rayaprolu, Gargi Borgharkar, Pavan Kumar Reddy Kalluru, Thanmai Reddy Thugu · 2023 · Cureus
90. Fungal metabolite nigerloxin ameliorates diabetic nephropathy and gentamicin-induced renal oxidative stress in experimental rats
    Bharathinagar S. Suresha, Krishnapura Srinivasan · 2014 · Naunyn-Schmiedeberg s Archives of Pharmacology
91. Appropriate drug therapy for improving outcomes in diabetic nephropathy
    Robert D. Toto · 2002 · Current Diabetes Reports
92. Attenuation of STZ-induced diabetic nephropathy byCucurbita pepoL. seed extract characterized by GCMS
    Navpreet Kaur, Lalit Kishore, Randhir Singh · 2017 · Journal of Food Biochemistry
93. Identifying and interpreting novel targets that address more than one diabetic complication: a strategy for optimal end organ protection in diabetes
    Shinji Hagiwara, Jay C. Jha, Mark Emmanuel Cooper · 2013 · Diabetology International
94. An Overview of Diabetic Nephropathy
    Kei Fukami, Sho‐ichi Yamagishi · 2012 · Elsevier eBooks
95. Pathophysiology and Pathogenesis of Diabetic Nephropathy
    Günter Wolf, Kumar Sharma, Fuad N. Ziyadeh · 2008 · Elsevier eBooks
96. WITHDRAWN: Effect of 2-dodecyl-6-methoxycyclohexa-2, 5-diene-1, 4-dione, isolated from Averrhoa carambola L. (Oxalidaceae) roots, on advanced glycation end-product-mediated renal injury in type 2 diabetic KKAy mice
    Ni Zheng, Xing Lin, Qingwei Wen, Kintoko, Shijun Zhang, Jianchun Huang, Xiaohui Xu, Renbin Huang · 2021 · Toxicology Letters · Retracted
97. The Investigation of the Effects of Enalapril and Losartan on Ghrelin Immunoreactivity in Kidney of Streptozotocin-Induced Diabetic Rats
    Emir Dönder, Murat Doğan, Tuncay Kuloğlu, Özlem Dürrin Dabak, Nevin Kocaman, Yusuf Özkan · 2013 · DergiPark (Istanbul University)
98. Effect of the Lycii Fructus on multiple low-dose streptozotocin-induced diabetic rats
    Tae Woo Oh, Yong-Ki Park · 2015 · The Korea Journal of Herbology
99. Effect of Citrullus Colocynthis Pulp on Renal Function in Streptozotocin-Induced Diabetic Rats
    Tayebeh Bagherizadeh, Ali Gol, Hakimeh Olomi · 2015 · Bimonthly Journal of Hormozgan University of Medical Sciences
100. No Association between Oxidative Stress and IL-6 in NIDDM Patients with Nephropathy
     Ş. Alsancak, M. Aydin, Alaattin Yıldız, Serpil Salman, Şule Seçkin · 2003 · Folia Biologica